dc.contributor.author | Newlove-Delgado, TV | |
dc.contributor.author | Ford, T | |
dc.contributor.author | Hamilton, W | |
dc.contributor.author | Janssens, A | |
dc.contributor.author | Stein, K | |
dc.contributor.author | Ukoumunne, O | |
dc.date.accessioned | 2019-03-25T10:34:57Z | |
dc.date.issued | 2019-04-04 | |
dc.description.abstract | This study aimed to examine resumption of Attention Deficit Hyperactivity Disorder (ADHD)
prescriptions in early adulthood in young people whose ADHD prescriptions stopped in adolescence.
Whilst prescribing studies indicate that the proportion of those with ADHD stopping treatment in late
adolescence remains in excess of the proportion expected to be symptom free, very few studies have
examined patterns of resumption amongst young adults previously prescribed medication.
Primary care records from the UK Clinical Practice Research Datalink from 2008 to 2013 were used
to examine the outcome of resumption of ADHD prescriptions from age 20 years in a sample of cases
with ADHD whose prescriptions stopped aged 14-18. A Cox regression model was fitted to explore
variables that could theoretically be associated with resumption of prescriptions.
Of 1,440 cases, 109 (7.6%) had their ADHD prescriptions resumed. Characteristics associated with an
increased probability of resumption included female gender, learning disability, referral to adult
mental health services, and prescription of antipsychotic medication.
In this study, only a small proportion of adolescents who stopped ADHD medication subsequently
resumed their prescriptions in primary care. Those that did resume were a more complex group. As
many vulnerable individuals with ongoing ADHD symptoms may not have the resources required to
surmount the barriers to re-enter services, the implication is that not all those who could benefit from
resuming medication are able to do so. The findings raise questions around whether current care
models are flexible enough and whether primary care are adequately supported in managing this
group. | en_GB |
dc.identifier.citation | Published online 04 April 2019. | en_GB |
dc.identifier.doi | 10.1007/s00787-019-01325-5 | |
dc.identifier.uri | http://hdl.handle.net/10871/36628 | |
dc.language.iso | en | en_GB |
dc.publisher | Springer (part of Springer Nature) | en_GB |
dc.rights | © The Author(s) 2019. Open Access, This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. | |
dc.subject | ADHD | en_GB |
dc.subject | Transition | en_GB |
dc.subject | Prescribing | en_GB |
dc.subject | Adolescents | en_GB |
dc.title | Resumption of Attention Deficit Hyperactivity Disorder medication in early adulthood: findings from a UK primary care prescribing study | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2019-03-25T10:34:57Z | |
dc.identifier.issn | 1018-8827 | |
dc.description | This is the author accepted manuscript. The final version is available from Springer via the DOI in this record. | en_GB |
dc.identifier.journal | European Child and Adolescent Psychiatry | en_GB |
dc.rights.uri | http://www.rioxx.net/licenses/all-rights-reserved | en_GB |
dcterms.dateAccepted | 2019-03-25 | |
exeter.funder | ::National Institute for Health Research (NIHR) | en_GB |
rioxxterms.version | AM | en_GB |
rioxxterms.licenseref.startdate | 2019-03-25 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2019-03-25T10:11:51Z | |
refterms.versionFCD | AM | |
refterms.dateFOA | 2019-04-05T12:32:13Z | |
refterms.panel | A | en_GB |